Grannus Therapeutics, Inc.
New Filing
CIK: 0001905806·Biotechnology·UNITED STATES·Filed: Jan 12, 2024
Total Offering
$800,000
Amount Sold
$800,000
Investors
9
First Sale
Nov 17, 2023
Offering Details
- Type
- Debt
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2020
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| John Foglesong | Related Person |
| Brian Blagg | Related Person |
Company
SEC Filing
0001905806-24-000004
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free